Tracheal intubation can be accompanied by significant increases in arterial pressure, heart rate and the plasma levels of noradrenaline and adrenaline. The drugs used at induction can enhance or attenuate these responses. In nine patients who had received gallamine, intubation was associated with a 45% rise in mean arterial pressure, a twofold rise in plasma adrenaline and a 49% rise in plasma noradrenaline concentration. When a mixture of pancuronium and alcuronium (in a ratio of 4: 1 0 by weight) was used in ten patients, blood pressure fell 24 % after induction and rose 49% after intubation. A 24% rise in plasma noradrenaline in response to intubation was also observed. Compared with pancuronium alone, the use of the mixture attentuates the rise in blood pressure and noradrenaline concentration associated with intubation but does not abolish them. In addition, the mixture was associated with a significant fall in blood pressure between induction and intubation, whereas this was not found with gallamine.
are also associated with rises in plasma noradrenaline and mean arterial pressure (MAP)!,3 but these rises are less than those seen with pancuronium. In contrast, intubation with alcuronium is not associated with a rise in noradrenaline or MAP. 4 In order to reduce the pressor effect of pancuronium some anaesthetists have now begun to use alcuronium mixed with pancuronium for relaxation. There is no information on the effect of gallamine with intubation, although cardiovascular changes with this relaxant are well recognised. This study examines the effects of a mixture of pancuronium and alcuronium and of gallamine on plasma catecholamine concentrations and MAP and the responses to subsequent endotracheal intubation. METHODS Nineteen patients aged from 20 to 81 years (mean 60.7 years) were studied. They randomly received either gallamine (2 mgkg-l ) or a mixture of pancuronium and alcuronium. The latter two relaxants were mixed in the one syringe in the ratio of alcuronium 10 mg to pancuronium 4 mg to a total volume of 4 ml and was administered on the basis of the patient's weight. Patients weighing less than 50 kg received 2 ml of the mixture, those who weighed 50 to 70 kg, 3 ml, and those over 70 kg, 4 m!. Induction was achieved with thiopentone and anaesthesia maintained with nitrous oxide and oxygen. No volatile agent was used during the sampling period.
Nine patients received gallamine and ten received the alcuronium/pancuronium mixture. The two groups were compared with respect to sex distribution, body weight and age and were found to be similar. Approximately equal numbers of patients received benzodiazepines and narcotics as premedication, and neither premedication appeared to alter the intubation response. Seven patients in each group were ASA 3, which reflects the fact that most were scheduled for vascular surgery. The remaining two patients given gallamine were ASA 1 and 2. The other three patients given the alcuronium/pancuronium mixture were ASA 2, 4 and 4.
On the night before surgery, the cannulation and the sampling procedure was explained to the patient and consent was obtained. An Allen's test was performed at this visit to confirm patency of the collateral circulation in the hand. Premedication was left to the preference of the individual anaesthetist and consisted of either a parenteral narcotic or an oral benzodiazepine.
Prior to surgery, a 20-gauge Venflon cannula was inserted into the radial artery under local anaesthesia. A continuous trace of arterial blood pressure was obtained using a Statham P231 D transducer with a Hewlett Packard combined ECG and blood pressure display and direct hot wire pen recorder. The system was zeroed against a fluid level at the mid-axillary line and calibrated against a mercury column.
Sampling of arterial blood was performed through the cannula via a three-way tap. One sample (5 m!) was obtained immediately before Anaesthesia and Intensive Care, Vol. 12, No. 1, February, 1984 induction (SI). After induction the patient was ventilated for five minutes and immediately before the trachea was intubated a sample was taken (S2) and again at one, five, and ten minutes after the tracheal intubation (S3, S4 and S5 respectively).
All samples were stored on ice in heparinised tubes (lithium heparin 125 U/lO ml) containing glutathione (5 mmolllitre) to prevent oxidation of the catecholamines. The tubes were transported on ice and centrifuged on completion of sampling. The decanted plasma was frozen and stored at -20 QC until the assay was performed which was always within two weeks. The assay used is a modification of the radio-enzymatic technique described by Da Prada and Ziircher in 1976. 5 This assay has a coefficient of variation for all catecholamines of less than 10070 at low levels, and about 5070 at levels comparable to those in this study, and a recovery rate of 60070 to 62070.
Results were analysed using the Student's t-test (paired and unpaired) for means. Results were given as mean and standard deviation where appropriate.
RESULTS
The group data for plasma catecholamines and MAP are shown in Table 1 . In four patients (one receiving the mixture and three gallamine), surgery was begun between the fiveand ten-minute sampling. These patients have been excluded from the ten-minute analysis.
The MAP before induction of anaesthesia (SI) was similar in both groups of patients; mean MAP 84 (SD 13) mmHg for gallamine and 90 (SD 14) mmHg for the relaxant mixture.
With gallamine on induction, the patient's MAP declined slightly to 75 (SD 13) mmHg (not statistically significantly different). The rise following intubation was marked, a mean of 33 (SD 39) mmHg or 45070 difference between the pressure just prior to intubation and the pressure just after intubation (p = 0.0006). This was also significantly higher than the average pre-induction pressure (p=0.OO04). In comparison with the level before intubation the pressure remained elevated at five minutes and ten minutes after intubation (p = 0.Q17 and 0.023 respectively).
The levels of all three catecholamines before induction were similar in the two groups. These 
1.4 (0.9) G = gallamine, P A = pancuronium and aicuronium mixture SI = before induction, S2 = immediately before intubation, S3 = I minute after intubation, S4 = 5 minutes after intubation, S5 = 10 minutes after intubation (note number of patients reduced at 10 minutes PA=9, G=6). All values are quoted as mean and SO.
mean levels were similar to those found previously, adrenaline = 0.36 (SD 0.34), dopamine=0.43 (SD 0.61), and noradrenaline = 1.78 (SD 1.10), pmol/ml, n = 88. These are combined values from previous studies in patients coming to theatre. 1 ,2,4 The plasma noradrenaline level for the gallamine group is significantly lower than the combined mean concentration (p = 0.01).
The changes in plasma catecholamine concentrations in the patients who received gallamine were selective. There were no significant changes in plasma dopamine at any sampling time but the other two catecholamines changed significantly. The adrenaline concentration fell between the pre-induction and pre-intubation samples (p = 0.01) and rose twofold from the time of the sample before intubation to one minute after intubation (p = 0.026). Thereafter, adrenaline remained close to the pre-induction level. Noradrenaline did not change significantly after induction but rose by 49070 after intubation (p = 0.006) and remained close to the post-intubation level thereafter.
With the pancuronium/alcuronium mixture mean MAP declined 24070 after induction (p = 0.001). Following intubation, the MAP rose 49070, exceeding the preinduction level by 13070 (p =0.03). However, the rise was not sustained and by five minutes after intubation the pressure was about the pre-induction concentration and remained so at ten minutes.
After the relaxant mixture, selective changes in catecholamines were seen also. Mean adrenaline levels slowly declined at each sampling time but only the difference between the pre-induction level and the sample ten minutes after intubation was statistically significant. In contrast, the mean level of noradrenaline fell from 1.54 to 1.34 pmol/ml after induction (p =0.031) and rose by 24070 after intubation to a mean of 1.66 pmol/ml (p =0.003). Again this rise was not sustained and the levels at five and ten minutes were similar to those before intubation.
Comparing the two techniques of competitive muscle relaxation, differences between their effects on blood pressure and plasma catecholamine seem slight. After induction the fall in MAP with the pancuronium/alcuronium mixture was significantly greater than that with gallamine (p = 0.05). The pressure rise with intubation was similar, although the pressure tended then to remain elevated with gallamine. Both groups showed a significant rise in noradrenaline with intubation. Patients given gallamine showed a rise also in the mean adrenaline level, which was not seen with the relaxant mixture after intubation, but this was not statistically significant at any time when compared with the concentrations found in patients given the mixture.
DISCUSSION
Pancuronium, alcuronium, d-tubocurarine, and gallamine differ in their effects on the cardiovascular system. Pancuronium causes modest increases in heart rate, cardiac output Anaesthesia and Intensive Care, Vo!. 12, No. I, February, 1984 and blood pressure which have been attributed to both a direct vagolytic effect and an indirect sympathomimetic effect. 6 The administration of alcuronium or d-tubocurarine is usually followed by a fall in MAP and a rise in heart rate. Gallamine has a vagolytic effect and causes tachycardia. Thus there is no competitive relaxant in current use devoid of cardiovascular side effects.
The usual sequel to the administration of a muscle relaxant is tracheal intubation, which is a potent sympathetic stimulus, and measuring plasma catecholamine concentrations during intubation has provided insight into their role in the cardiovascular changes.
Previous work has shown that when pancuronium is used, intubation is accompanied by a sharp rise in the plasma level of noradrenaline and a lesser rise in adrenaline with a parallel rise in MAP . 1, 2, 3, 8 By contrast, patients given alcuronium show no significant change in the plasma level of any catecholamine nor in MAP in response to intubation. 4 It was thus of considerable interest to study the effects of a mixture of these two relaxants on the cardiovascular and catecholamine response to intubation. If the results of this study with the alcuronium/pancuronium are compared with the previous results using pancuronium or alcuronium alone,4 several differences are seen. In that study with pancuronium, the MAP one minute after intubation was very elevated. With alcuronium, the MAP one minute after intubation was unchanged. Both these responses differ from that found with the mixture; the response in the presence of pancuronium alone is more marked and with alcuronium alone there is no pressor response. However, hypotension occurs after induction but before intubation both with alcuronium alone and with the mixture. Thus although the mixture of relaxants may attenuate the pressor effect of intubation, there is no clear advantage over alcuronium alone which abolishes the response.
With gallamine, there was no significant fall in MAP after intubation and there was an increase in the level of noradrenaline, adrenaline and MAP after intubation. Gallamine thus behaves like pancuronium, sustaining blood pressure after induction but accentuating the responses to intubation. The Anaesthesia and Intensive Care, Vol. 12, No. I, February, 1984 use of d-tubocurarine is associated with a significant fall in MAP after induction, but there is no attenuation of the pressure rise on intubation.! Thus except for alcuronium, most relaxants, including the mixture, are associated with pressure and catecholamine swings during intubation. If a patient's condition requires that any rise in MAP or catecholamine concentrations be avoided, then alcuronium seems to confer an advantage. However, the risk of hypotension must be accepted.
The abnormally low mean level of noradrenaline in the gallamine group before induction is hard to explain. Neither premedication, age, nor ASA status differed substantially from the group given the mixture. There is, however, a problem of data interpretation. The percentage increase in noradrenaline concentration from before to after intubation was greater for gallamine, 49070 versus 23 %. However, the mean noradrenaline concentration reached was greater with the mixture.
This study shows that neither gallamine nor an alcuronium/pancuronium mixture allows intubation without substantial changes in MAP and plasma noradrenaline. Gallamine would be a reasonable choice if sustaining blood pressure was a major consideration. The mixture seems likely to cause pre-intubation hypotension and yet allow a post-intubation pressor response. If the avoidance of hypertensive response after intubation is deemed to be desirable, the mixture is an incomplete answer.
